http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1426199-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D499-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-66
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K20-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D499-64
filingDate 1973-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1976-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1426199-A
titleOfInvention Penicillins their production and their medicinal use
abstract 1426199 Penicillins BAYER AG 30 Nov 1973 [1 Dec 1972 4 April 1973] 55668/73 Addition to 1301962 Heading C2C The invention comprises the compounds of formula and their salts, wherein (i) R is Me and B is either 1,4-cyclohexadien-1-yl or p-hydroxyphenyl, or (ii) R is H and B is 1,4-cyclohexadien-1-yl. In examples, these compounds are prepared by reacting the corresponding NH 2 -terminated penicillin with 2-oxo-imidazolidin-1-carbonyl chloride or its N-methyl derivative, and are converted to the Na salts. Pharmaceutical and veterinary compositions having antibacterial and growth promoting activity comprise compounds of the above formula, and may be administered orally, parenterally, rectally or locally.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4229348-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4355038-A
priorityDate 1972-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID83241
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP14188
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553743
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP20294
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51642
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP26441
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO02732
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415776829

Total number of triples: 37.